These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9675226)
41. Synthesis and affinity evaluation of a small library of bidentate cholera toxin ligands: towards nonhydrolyzable ganglioside mimics. Cheshev P; Morelli L; Marchesi M; Podlipnik C; Bergström M; Bernardi A Chemistry; 2010 Feb; 16(6):1951-67. PubMed ID: 20039344 [TBL] [Abstract][Full Text] [Related]
42. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies]. Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060 [TBL] [Abstract][Full Text] [Related]
44. Calculation of the conformation of glycosphingolipids. 2. GM1- and GM2-gangliosides. Wynn CH; Robson B J Theor Biol; 1986 Nov; 123(2):221-30. PubMed ID: 3626589 [TBL] [Abstract][Full Text] [Related]
45. Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides. Watarai S; Kushi Y; Shigeto R; Misawa N; Eishi Y; Handa S; Yasuda T J Biochem; 1995 May; 117(5):1062-9. PubMed ID: 8586620 [TBL] [Abstract][Full Text] [Related]
46. Glycopolymers Mimicking GM1 Gangliosides: Cooperativity of Galactose and Neuraminic Acid for Cholera Toxin Recognition. Terada Y; Hoshino Y; Miura Y Chem Asian J; 2019 Apr; 14(7):1021-1027. PubMed ID: 30809935 [TBL] [Abstract][Full Text] [Related]
47. Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro. Hedberg KM; Dellheden B; Wikstrand CJ; Fredman P Glycoconj J; 2000 Oct; 17(10):717-26. PubMed ID: 11425192 [TBL] [Abstract][Full Text] [Related]
48. Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin. Hansson HA; Holmgren J; Svennerholm L Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3782-6. PubMed ID: 269432 [TBL] [Abstract][Full Text] [Related]
49. Capping of cholera toxin-ganglioside GM1 complexes on mouse lymphocytes is accompanied by co-capping of alpha-actinin. Kellie S; Patel B; Pierce EJ; Critchley DR J Cell Biol; 1983 Aug; 97(2):447-54. PubMed ID: 6684122 [TBL] [Abstract][Full Text] [Related]
50. Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods. O'Shannessy DJ; Brigham-Burke M; Soneson KK; Hensley P; Brooks I Anal Biochem; 1993 Aug; 212(2):457-68. PubMed ID: 8214588 [TBL] [Abstract][Full Text] [Related]
51. Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside. Livingston PO; Ritter G; Srivastava P; Padavan M; Calves MJ; Oettgen HF; Old LJ Cancer Res; 1989 Dec; 49(24 Pt 1):7045-50. PubMed ID: 2582446 [TBL] [Abstract][Full Text] [Related]
52. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies? Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254 [TBL] [Abstract][Full Text] [Related]
53. Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome. Willison HJ; O'Hanlon G; Paterson G; O'Leary CP; Veitch J; Wilson G; Roberts M; Tang T; Vincent A J Infect Dis; 1997 Dec; 176 Suppl 2():S144-9. PubMed ID: 9396699 [TBL] [Abstract][Full Text] [Related]
54. Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2). Young WW; MacDonald EM; Nowinski RC; Hakomori SI J Exp Med; 1979 Oct; 150(4):1008-19. PubMed ID: 512581 [TBL] [Abstract][Full Text] [Related]
55. Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. Holmgren J; Lönnroth I; Månsson J; Svennerholm L Proc Natl Acad Sci U S A; 1975 Jul; 72(7):2520-4. PubMed ID: 1058471 [TBL] [Abstract][Full Text] [Related]
56. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies. Ohta S; Igarashi S; Honda A; Sato S; Hanai N Anticancer Res; 1993; 13(2):331-6. PubMed ID: 8517645 [TBL] [Abstract][Full Text] [Related]
57. Human monoclonal antibody to ganglioside GM2 for melanoma treatment. Irie RF; Matsuki T; Morton DL Lancet; 1989 Apr; 1(8641):786-7. PubMed ID: 2564593 [No Abstract] [Full Text] [Related]
59. Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity. Chapman PB; Lonberg M; Houghton AN Cancer Res; 1990 Mar; 50(5):1503-9. PubMed ID: 2105840 [TBL] [Abstract][Full Text] [Related]
60. Differential endocytic trafficking of neuropathy-associated antibodies to GM1 ganglioside and cholera toxin in epithelial and neural cells. Iglesias-Bartolomé R; Trenchi A; Comín R; Moyano AL; Nores GA; Daniotti JL Biochim Biophys Acta; 2009 Dec; 1788(12):2526-40. PubMed ID: 19800863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]